MO039 The 24-week interim analysis results of a randomized, double-blind, Placebo-Controlled Phase II Study of atacicept in patients with IGA nephropathy and persistent proteinuria
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.